http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#Head http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#assertion http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#provenance http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#pubinfo http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#assertion http://purl.obolibrary.org/obo/DOID_1781 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1781 http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00451 http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#association http://www.w3.org/2000/01/rdf-schema#label tirosint is l thyroxine t4 indicated for adults and pediatric patients 6 years and older with hypothyroidism as replacement therapy in primary thyroidal secondary pituitary and tertiary hypothalamic congenital or acquired hypothyroidism 1 pituitary thyrotropin thyroid stimulating hormone tsh suppression as an adjunct to surgery and radioiodine therapy in the management of thyrotropin dependent well differentiated thyroid cancer 1 limitations of use not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine sufficient patients 1 not indicated for treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis 1 hypothyroidism tirosint is indicated as a replacement therapy in adults and pediatric patients 6 years and older with primary thyroidal secondary pituitary and tertiary hypothalamic congenital or acquired hypothyroidism pituitary thyrotropin thyroid stimulating hormone tsh suppression tirosint is indicated as an adjunct to surgery and radioiodine therapy in the management of adults and pediatric patients 6 years and older with thyrotropin dependent well differentiated thyroid cancer limitations of use tirosint is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine sufficient patients as there are no clinical benefits and overtreatment with tirosint may induce hyperthyroidism see warnings and precautions 5 4 tirosint is not indicated for treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB00451 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#provenance http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#pubinfo http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#sig http://purl.org/nanopub/x/hasSignature VFOu5QCFaUxro8nhL4L4yR0+1GK85n3NIYzipoEnqCqc5FA3c4E5eYqlxUgmG6LRrHZNKhoUMDSjYw3NhjdQfDpBkOqqgWqbAsL69CnMsQSzMLdIPpMXTWiLYT7BpKmgomDQG1eozX7Jjl5yXBXCeAOWSK5NOOg++P1ptwBpAjs= http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag http://purl.org/dc/terms/created 2021-06-19T08:31:48.544+02:00 http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAzuVlxCgi7e4W9Eb4KFCLyqthYJblQW98r_criXqUVag https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs